KR960702835A - 헤테로사이클릭 화학(Heterocyclic chemistry) - Google Patents

헤테로사이클릭 화학(Heterocyclic chemistry)

Info

Publication number
KR960702835A
KR960702835A KR1019950705467A KR19950705467A KR960702835A KR 960702835 A KR960702835 A KR 960702835A KR 1019950705467 A KR1019950705467 A KR 1019950705467A KR 19950705467 A KR19950705467 A KR 19950705467A KR 960702835 A KR960702835 A KR 960702835A
Authority
KR
South Korea
Prior art keywords
heterocyclic chemistry
hydrogentartrate
thiadiazol
methylpyridine
hexyloxy
Prior art date
Application number
KR1019950705467A
Other languages
English (en)
Other versions
KR100339115B1 (ko
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of KR960702835A publication Critical patent/KR960702835A/ko
Application granted granted Critical
Publication of KR100339115B1 publication Critical patent/KR100339115B1/ko

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hospice & Palliative Care (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Psychiatry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
KR1019950705467A 1993-06-04 1994-05-26 결정성3-(4-헥실옥시-1,2,5-티아디아졸-3-일)-1,2,5,6-테트라하이드로-1-메틸피리딘(+)l-하이드로겐타르트레이트,이의제조방법및이를포함하는약제학적조성물 KR100339115B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7257293A 1993-06-04 1993-06-04
US08/072572 1993-06-04
PCT/DK1994/000205 WO1994029303A1 (en) 1993-06-04 1994-05-26 Heterocyclic chemistry

Publications (2)

Publication Number Publication Date
KR960702835A true KR960702835A (ko) 1996-05-23
KR100339115B1 KR100339115B1 (ko) 2002-11-07

Family

ID=22108479

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950705467A KR100339115B1 (ko) 1993-06-04 1994-05-26 결정성3-(4-헥실옥시-1,2,5-티아디아졸-3-일)-1,2,5,6-테트라하이드로-1-메틸피리딘(+)l-하이드로겐타르트레이트,이의제조방법및이를포함하는약제학적조성물

Country Status (22)

Country Link
US (1) US5834495A (ko)
EP (1) EP0703915B1 (ko)
JP (1) JP3190679B2 (ko)
KR (1) KR100339115B1 (ko)
CN (1) CN1064681C (ko)
AT (1) ATE196631T1 (ko)
AU (1) AU698673B2 (ko)
CA (1) CA2164296C (ko)
CZ (1) CZ290550B6 (ko)
DE (1) DE69426021T2 (ko)
DK (1) DK0703915T3 (ko)
ES (1) ES2152315T3 (ko)
FI (1) FI955829A (ko)
GR (1) GR3035033T3 (ko)
HU (1) HUT75038A (ko)
IL (1) IL109866A (ko)
NO (1) NO305560B1 (ko)
NZ (2) NZ267062A (ko)
PT (1) PT703915E (ko)
SK (1) SK281980B6 (ko)
WO (1) WO1994029303A1 (ko)
ZA (1) ZA943904B (ko)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0821956A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating disruptive behavior disorders
US6117890A (en) * 1996-08-01 2000-09-12 Eli Lilly And Company Method for treating bipolar disorder
US6043258A (en) * 1996-08-01 2000-03-28 Eli Lilly And Company Method for treating disruptive behavior disorders with xanomeline
US6090829A (en) * 1996-08-01 2000-07-18 Eli Lilly And Company Method for treating excessive aggression
EP0821954A1 (en) * 1996-08-01 1998-02-04 Eli Lilly And Company Method for treating mental retardation
US6034108A (en) * 1997-07-28 2000-03-07 Eli Lilly And Company Method for treating mental retardation
EP3265128A4 (en) * 2015-03-06 2018-09-12 Chase Pharmaceuticals Corporation Oxybutynin transdermal therapeutic system muscarinic agonist combination
WO2023061372A1 (zh) * 2021-10-14 2023-04-20 南京迈诺威医药科技有限公司 占诺美林衍生物的苹果酸盐、a晶型及其制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5043345A (en) * 1989-02-22 1991-08-27 Novo Nordisk A/S Piperidine compounds and their preparation and use
US5260311A (en) * 1989-02-22 1993-11-09 Novo Nordisk A/S Piperidine compounds and their use
US5264444A (en) * 1989-02-22 1993-11-23 Novo Nordisk A/S Piperidine compounds and use

Also Published As

Publication number Publication date
HU9503453D0 (en) 1996-01-29
SK281980B6 (sk) 2001-09-11
NO954892L (no) 1995-12-01
EP0703915B1 (en) 2000-09-27
NZ336733A (en) 2001-02-23
FI955829A0 (fi) 1995-12-04
KR100339115B1 (ko) 2002-11-07
CN1128999A (zh) 1996-08-14
CN1064681C (zh) 2001-04-18
JP3190679B2 (ja) 2001-07-23
PT703915E (pt) 2001-03-30
DE69426021T2 (de) 2001-05-17
AU698673B2 (en) 1998-11-05
FI955829A (fi) 1995-12-04
NO305560B1 (no) 1999-06-21
EP0703915A1 (en) 1996-04-03
CZ321095A3 (en) 1996-09-11
CZ290550B6 (cs) 2002-08-14
NO954892D0 (no) 1995-12-01
CA2164296A1 (en) 1994-12-22
ZA943904B (en) 1995-12-04
NZ267062A (en) 1999-09-29
ATE196631T1 (de) 2000-10-15
US5834495A (en) 1998-11-10
SK152095A3 (en) 1996-10-02
GR3035033T3 (en) 2001-03-30
WO1994029303A1 (en) 1994-12-22
CA2164296C (en) 2007-01-23
IL109866A (en) 2000-06-01
AU6924294A (en) 1995-01-03
DK0703915T3 (da) 2001-01-22
IL109866A0 (en) 1994-10-07
DE69426021D1 (de) 2000-11-02
ES2152315T3 (es) 2001-02-01
HUT75038A (en) 1997-03-28
JPH08511008A (ja) 1996-11-19

Similar Documents

Publication Publication Date Title
NO881697D0 (no) Verktoeyenhet, verktoeydeler og fremgangsmaate for sammensetting av delene.
NO893304D0 (no) Heterocykliske forbindelser.
DE69005858D1 (de) Heterocyclische Verbindungen.
NL300035I2 (nl) Gesubstitueerde thiazolidinedionderivaten.
GB9514473D0 (en) Chemical compounds
DE59100656D1 (de) Bohrfutter.
MX9700696A (es) Compuestos heterociclicos, utiles como productores de efecto aloesterico en receptores muscarinicos.
DE69105462D1 (de) Desinfizierende Zusammensetzung.
TR28098A (tr) 1,2,4-okzadiazol türevleri.
FI952682A (fi) Insektisidisiä 5-substituoituja 2,4-diamiinipyrimidiinijohdannaisia
FI941776A (fi) Menetelmä 1,2,4-tiadiatsolien valmistamiseksi
FI962976A (fi) Viherkaihin hoitoon tarkoitettuja koostumuksia, jotka sisältävät beta-salpaajaa
KR960702835A (ko) 헤테로사이클릭 화학(Heterocyclic chemistry)
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
MY105128A (en) Bu-3608 derivatives.
DE69406836D1 (de) Teilweise als Fungizide verwendbare 3,4-Dioxy-1,2,5-thiadiazole
EP0038003A3 (en) Antidepressant pyrrolylpiperidines
DE68900131D1 (de) Biozide 4,5-dichlor-1,2-dithiol-3-on-zusammensetzung.
ATE68486T1 (de) 1-((2-fluorophenyl)(4-fluorophenyl)phenylmethyl - 1h-imidazol.
BR9105402A (pt) Compostos 2,6-alcoxifenil-alquilcetonas e composicoes herbicidas contendo os mesmos
OA09328A (en) "Heterocyclic compounds".
DE68910907D1 (de) Fungizide Zusammensetzungen.
NO932258D0 (no) Heterocykliske, skadedyrdrepende forbindelser
DE59005786D1 (de) Heterocyclische Verbindungen.
SU1432991A1 (ru) 4-Метил-5-(4-метилфениламино)-1,2,3-триазол, обладающий противовоспалительной активностью

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
LAPS Lapse due to unpaid annual fee